StreamRX blog

Insights & intelligence

Expert perspectives on pharmacy operations, Medicare strategy, self-funded plans, and digital transformation.

13 articles
Self-Funded

Fiduciary Duty and Pharmacy Benefits: What Self-Funded Plan Sponsors Need to Know

Selecting and monitoring a PBM is an ERISA fiduciary act. Here is what the lawsuits against J&J, Wells Fargo, and JPMorgan mean, how the 2026 PBM law changes oversight, and what a prudent, documented pharmacy benefit process looks like.

Read article
Self-Funded

Can Cost-Plus Pharmacies Save a Self-Funded Plan Money?

Cost-plus pharmacies publish their pricing, and research shows big savings on some generics. Here is what the evidence says, the difference between plan savings and member savings, four ways self-funded plans use cost-plus, and the watch-outs.

Read article
Medicare

2027 Medicare Part D Changes: What Pharmacies Need to Know Before January 1

15 more negotiated-price drugs, fewer stand-alone plans, a $2,400 out-of-pocket cap, and the end of premium stabilization. Here's what changes in Medicare Part D for 2027, how MFP refunds affect pharmacy cash flow, and a checklist to work through before January 1.

Read article
Self-Funded

Biosimilars: Is Your Self-Funded Plan Still Paying Brand Prices?

Humira biosimilars now hold most of the market and Stelara biosimilars launched at deep discounts. Here is where adoption stands, why your plan may still pay brand-level prices, private-label biosimilars, and how to switch members well.

Read article
Self-Funded

Specialty Drugs Are Half Your Pharmacy Spend: 5 Ways Self-Funded Plans Manage Them

Specialty drugs are a small share of prescriptions but roughly half of pharmacy spend, and growing fastest. Here are the latest benchmarks and five practical levers: one budget, site of care, biosimilars, the specialty pharmacy channel, and clinical management.

Read article
Self-Funded

5 Costly Mistakes Self-Funded Employers Make With Their Drug Benefit Plans (And How to Fix Them)

Discover the 5 critical, multi-million dollar mistakes self-insured plan sponsors make with their pharmacy benefits, from GLP-1 overspend traps to PBM billing blind spots, and concrete strategies to mitigate them immediately.

Read article
Self-Funded

Are You Leaving Money on the Table? How Self-Funded Employers Are Quietly Overpaying for Prescription Drugs

Prescription drug costs are the fastest-growing line item in most employer health plans today. Discover the hidden economics of PBM plans, the brand-to-generic gap, the rebate trap, and steps to optimize your pharmacy spend.

Read article
Policy

PBM Reform in 2026: What Independent Pharmacies Need to Understand

2026 marks a turning point for PBM legislation. From the fall of spread pricing to the rise of the Mark Cuban model, we analyze a landscape defined by radical transparency and legislative pressure.

Read article
Web Design

3 Ways a Pharmacy Can Improve Its Website

Discover three critical strategies to improve your independent pharmacy's website. Optimize for local search, mobile users, and clinical service growth in a digital-first world.

Read article
Medicare

Mastering Medicare Part D Reimbursement

Master Medicare Part D reimbursement in 2024. Learn how to navigate DIR fees, optimize medication tiers, and protect your pharmacy's margins with real-time data insights.

Read article
Consulting

The Future of Independent Pharmacy Consulting

Explore the evolution of independent pharmacy consulting. Learn how clinical pivots, operational efficiency, and veteran guidance are essential for navigating 2024's regulatory landscape.

Read article
Technology

AI and Automation in Pharmacy: Practical Applications Transforming Daily Operations

Explore how artificial intelligence and advanced automation are revolutionizing pharmacy workflows, from dispensing precision to proactive patient communication.

Read article

Stay ahead with specialized insights

Join independent pharmacy owners and Medicare experts receiving our bi-weekly intelligence report.